Recent studies indicate that the drug is making seniors healthier and helping stem the tide of the opioid epidemic—all while making their health care cheaper.
Democrats aren’t happy with the $1.1 billion deal, which includes millions in offsets.
The House GOP’s health-care proposal would expand savings accounts, provide tax credits for buying insurance, and allow people to purchase coverage across state lines. Just don’t ask how much it costs.
New research suggests a strong link between the public revelation of the Tuskegee Study and poor health outcomes for black men.
A federal judge’s ruling against the administration vindicated the GOP's try-anything strategy to derail the Affordable Care Act.
A decade after a judge ordered tobacco companies to acknowledge the dangers of low-tar cigarettes, they continue to dispute the scientific consensus.
Landmark breakthroughs in cancer treatment and a policy structure where those advances can flourish have given fuel to the ambitious “Moonshot” to cure the disease. But is it really possible?
A new law in Mississippi makes it legal for physicians and therapists to opt out of care on religious grounds. What does this mean for medicine?
An international team headlined by Richard Branson is trying to roll back the global war on drugs. And it’s getting started on the American front.
And when they find out, they don’t like it.
The number of Americans whose health-insurance plans qualify for the levy is sure to grow.
What should you fear? The answers are different at each stage of life—and vary dramatically for different groups of Americans.
The Republican presidential candidate and his Senate colleague, Mike Lee, want Americans to be able to buy drugs that have been approved by other developed countries.
A study finds that deadly attacks inspire copycat crimes for an average of 13 days after they occur.